Published in Cancer Weekly, April 18th, 2000
"Thirty-five patients received 105AD7 human anti-idiotype vaccination prior to surgery for colorectal carcinoma," stated L.G. Durrant and colleagues, University of Nottingham, England. "Patients were immunized before and also received one to two immunizations after surgical resection of their colorectal cancer."
Durrant et al. published the results of their study in Clinical Cancer Research ("A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55," Clin Cancer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.